- Home
- SBFM vs AIDX Comparison
SBFM vs AIDX Comparison
Compare SBFM & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBFM | AIDX |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.9M |
| IPO Year | 2008 | 2025 |
Fundamental Metrics
Financial Performance| Metric | SBFM | AIDX |
|---|---|---|
| Price | $0.17 | $0.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 10.1M | 111.4K |
| Earning Date | 11-12-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.48 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,305,891.00 | $2,045,133.00 |
| Revenue This Year | $1.23 | $44.20 |
| Revenue Next Year | $22.44 | $95.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.11 | ★ 16.71 |
| 52 Week Low | $0.19 | $0.26 |
| 52 Week High | $21.30 | $18.96 |
Technical Indicators
Market Signals| Indicator | SBFM | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 25.50 | 23.84 |
| Support Level | N/A | N/A |
| Resistance Level | $1.26 | $0.69 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 0.81 | 0.80 |
Price Performance
Historical ComparisonAbout SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.